Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer

Sarah Yoon, Eun Ju Lee, Ji Hye Choi, Taek Chung, Do Young Kim, Jong Yeop Im, Myung Ho Bae, Jung Hee Kwon, Hyuk Hoon Kim, Hyung Chul Kim, Young Nyun Park, Hee Jung Wang, Hyun Goo Woo

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Agricultural and Biological Sciences